Suxibuzone
Product Description
Srs Life Sciences Pte. Ltd.
-
Country/Region:Singapore
-
On CPHI since:2016
-
Certificates:1
-
Employees:100 - 249
Company types
Primary activities
Categories
Specifications
Srs Life Sciences Pte. Ltd.
-
Country/Region:Singapore
-
On CPHI since:2016
-
Certificates:1
-
Employees:100 - 249
Company types
Primary activities
More Products from Srs Life Sciences Pte. Ltd. (25)
-
Product Deferoxamine mesylate
The API will be used for the development of generic version of Desferal injection -
Product Cefuroxime Axetil
SRS Life Sciences Pte ltd offers a wide range of products which includes Cefuroxime Axetil. It belongs to ANTIBIOTICS AND ANTIBACTERIALS category. Form: Dry Powder Suspension. Strength: 125mg, 250mg. Pack Type: Sachets. Packing Style: 10's. Contact us for more information. -
Product Ertugliflozin Tablets
Ertugliflozin tablets, marketed under the brand names STEGLATRO, STEGLUJAN, and SEGLUROMET, is still under development. -
Product L-Glutamine oral powder
Developed in India, a generic version of Endari approved in US -
Product Levetiracetam granules for oral solution in sachet
Meets the EU RLD Neuraxpharm granules, The formulation is available in both forms, Sprinkle or generic -
Product Spherical Carbon Adsorbent in fine granules
Meets the Japan RLD Kremezin granules, worldwide charcoal tablets are already available. The carbon in granule form is more easy to use -
Product Acetylcysteine Sachet 100mg, 200mg, 600mg
RLD used is Fluimucil (Zambon) and it is developed for Philippines. Product is open for outlicensing for Emerging countries. -
Product Alfuzosin HCl ER Tablets 10 mg
RLD used is Xatral OD . The product is being developed for Emerging nations. -
Product Aspirin - Citric acid - Sodium Bicarbonate (heat treated) Effervescent Tablet 325mg-1000mg-1916mg
Product is being developed against Alka Seltzer by Bayer for US. Product would be registered as OTC. Product is available for outlicensing for US, EU and Emerging markets. -
Product Aspirin sachet 500 mg
Product is being developed against Bayer's for US. Product would be registered as OTC. Product is available for out-licensing for US, EU and Emerging markets. -
Product Cholestryamine Resin (Anhydrous) powder for oral suspension 4g
RLD is Cholestyramine sachets (Epic Pharma) and it is developed for Philippines. Product is open for outlicensing for Emerging countries. -
Product Fosfomycin Trometamol granules for oral solution 3g
RLD used is Zambon and product is available for out-licensing in EU countries and Brazil
Srs Life Sciences Pte. Ltd. resources (1)
-
Video SRS Life Sciences Pte Ltd at CPHI Worldwide 2018
Rajah Dubey, Chief Technical Strategist of SRS Life Sciences, speaks with CPHI TV at CPHI Worldwide in Madrid.
